Alder Matthias
- SEC CIK
- 0001370820
No open-market purchases or sales filed in the past year.
Current role at each company
- GANX Gain Therapeutics, Inc.Chief Executive Officeras of Mar 28, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Alder Matthias as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2023 (view filing) | Dec 21 | 1 day | Alder MatthiasChief Executive Officer | SSale | −206 | $2.46 | −$506.76 | −3.8%5.29K after | |
| Dec 14, 2023 (view filing) | Dec 7 | 7 daysLate | Alder MatthiasChief Executive Officer | SSale | −1.82K | $2.50 | −$4.55K | −27.3%4.86K after |